Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
3.740
+0.535 (16.69%)
At close: Nov 4, 2024, 4:00 PM
3.690
-0.050 (-1.34%)
After-hours: Nov 4, 2024, 4:47 PM EST

Cardiff Oncology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
0.670.490.390.360.370.24
Upgrade
Revenue Growth (YoY)
61.41%26.42%7.52%-1.91%49.61%-35.34%
Upgrade
Cost of Revenue
33.2932.8627.1117.3811.2411.16
Upgrade
Gross Profit
-32.62-32.37-26.72-17.02-10.87-10.92
Upgrade
Selling, General & Admin
12.0113.0413.1811.848.225.76
Upgrade
Operating Expenses
12.0113.0413.1811.848.225.76
Upgrade
Operating Income
-44.63-45.41-39.9-28.86-19.09-16.68
Upgrade
Interest Expense
-----0-
Upgrade
Interest & Investment Income
3.814.071.580.260.090.23
Upgrade
Other Non Operating Income (Expenses)
-0.03-0.1-0.380.3-0.310.03
Upgrade
EBT Excluding Unusual Items
-40.86-41.44-38.7-28.29-19.31-16.41
Upgrade
Pretax Income
-40.86-41.44-38.7-28.29-19.31-16.41
Upgrade
Net Income
-40.86-41.44-38.7-28.29-19.31-16.41
Upgrade
Preferred Dividends & Other Adjustments
0.020.020.020.023.290.29
Upgrade
Net Income to Common
-40.88-41.47-38.73-28.32-22.6-16.71
Upgrade
Shares Outstanding (Basic)
45454439216
Upgrade
Shares Outstanding (Diluted)
45454439216
Upgrade
Shares Change (YoY)
0.93%2.47%11.71%86.97%249.44%156.37%
Upgrade
EPS (Basic)
-0.91-0.93-0.89-0.73-1.08-2.80
Upgrade
EPS (Diluted)
-0.92-0.93-0.89-0.73-1.08-2.80
Upgrade
Free Cash Flow
-32.47-31.47-34.83-23.25-16.53-13.34
Upgrade
Free Cash Flow Per Share
-0.73-0.70-0.80-0.60-0.79-2.23
Upgrade
Operating Margin
-6711.28%-9305.74%-10337.31%-8037.60%-5214.75%-6817.79%
Upgrade
Profit Margin
-6147.52%-8496.93%-10033.16%-7887.19%-6174.32%-6829.31%
Upgrade
Free Cash Flow Margin
-4882.56%-6448.57%-9022.28%-6474.93%-4515.30%-5451.09%
Upgrade
EBITDA
-44.21-45.01-39.67-28.4-18.62-16.18
Upgrade
D&A For EBITDA
0.420.40.240.450.470.49
Upgrade
EBIT
-44.63-45.41-39.9-28.86-19.09-16.68
Upgrade
Revenue as Reported
-----0.24
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.